Release date: 2017-03-06

"If I can see it, life may be completely different... is it that God has covered the curtain in front of my eyes and forgot to open it."

In 2002, Xiao Huangqi, a singer who was blinded by congenital cataract, launched the song "You are my Eye", and even deep personal feelings have revealed the dilemma caused by visual impairment. In May 2015, the world's first bioengineered cornea “Ai Xinyi”, which was independently researched and developed by researchers of China Regenerative Medicine Group, was approved for the market, bringing light and hope to patients with visual impairment who are waiting in the dark night.

Recently, the reporter walked into Shenzhen Ai Niang Corneal Engineering Co., Ltd. (hereinafter referred to as “Ai Nier”), a subsidiary of China Regenerative Medicine Group located in Zhonghaixin Innovation Industrial City, Longgang District, to explore the porcine cornea--"Ai Xinyi "The story behind R&D and production.

Launched the second generation product full-layer cornea development

When Ai Xinyi appeared, it caused a sensation in the medical profession. The reporter learned from Ai Nier that the company has launched the research and development of the second-generation product "full-layer cornea". In the near future, this Longgang local company will once again be amazing in the world.

"We are working with the Shandong Institute of Ophthalmology, led by Xie Lixin, the only academician in China's ophthalmology industry, to develop a second-generation product that takes about four to five years and will be available in the fastest 2021." Vice President, China Regenerative Medicine Group, Zhang Ai, general manager of Ai Nier, said.

Ai Xinyi's second-generation product development team consists of five elite researchers. Each member has a strong background in research, one of whom returned from studying in Sweden and one returned from studying in the UK. The reporter learned from the R&D team that the research and development of the second generation products is progressing smoothly.

Unlike the first generation, the second generation contains an active layer of endothelial cells. According to Zhang Aibing, the human cornea has the characteristics of thin middle and thick sides, and its normal thickness is about 600 microns. The human cornea is divided into 5 layers, and the outermost non-keratinized squamous epithelium with a thickness of about 50 microns is called the corneal epithelium. Corneal epithelium and stromal layer are often damaged by disease or trauma, which can lead to blindness. It can be treated with laminectomy by Aisin. "If the endothelial layer of the patient's cornea is damaged, it can only be replaced by a fresh donor cornea, and this cornea is seriously lacking. The second generation of Ai Xinyi is expected to solve this problem."

Successfully performed nearly 500 cases of corneal transplantation

Zhang Aibing introduced that in 2015, Ai Nier established the Bioengineered Corneal Transplantation Expert Committee and established two bioengineered corneal transplant training bases in China, one in Beijing and one in Shandong. “This year, we plan to build another four training bases.” Currently, Ai Nier has trained 303 doctors with bioengineered corneal transplant capabilities worldwide and successfully conducted nearly 500 cases in over 100 hospitals across the country. Bioengineered corneal transplant surgery.

Zhang Aibing told the reporter about the story of the first person in South China who received a bioengineered corneal transplant to restart a bright life.

In the Spring Festival of 2016, Li, a 14-year-old boy from Jiangxi, was accidentally injured by firecrackers, causing corneal ulcers and facing the risk of blindness. Parents took him to the Zhongshan Ophthalmology Center of Sun Yat-sen University, but the infection could not be effectively controlled after drug treatment, and corneal transplantation surgery was necessary for further treatment. After communicating with the parents, the attending doctor decided to use the Ai Xinyi bioengineering cornea to complete the surgical treatment plan.

On February 25, 2016, a corneal transplant surgeon successfully performed a bioengineered corneal transplant for the patient. After half a year of recovery, the child's vision returned to 1.2, close to the vision before the injury.

How much does it cost to perform a corneal transplant? Can ordinary people afford "high technology"?

Zhang Aibing said that the price of a cornea is between 18,000 yuan and 20,000 yuan, plus the surgery fee, which costs about 30,000 yuan. “At present, among the groups that are in urgent need of corneal transplantation, farmers and disadvantaged groups with poor economic status account for a considerable part. In the next stage, we intend to cooperate with local charities to solve the problem of surgery costs for more patients. ”

The annual output value will reach more than 500 million yuan in the future.

Talking about the company's future development plan, Zhang Aibing said that Ai Nier has entered the product sales stage since 2016, with an annual output value of about 10 million yuan. At present, the company has an annual production capacity of 30,000 pieces of Ai Xinyi, the next 5 to 10 During the year, the annual output value is expected to reach more than 500 million yuan.

In the product planning of Ai Xinyi, on the one hand, Ai Nier plans to enrich the Aixin’s by investing in the fields of economic preoperative examination equipment, surgical consumables, postoperative consensus medications, etc. through the same industry mergers and acquisitions and research and development. On the other hand, a corneal transplantation package will be provided to improve the understanding of corneal transplantation in primary hospitals, simplify the medical process, and quickly pull the corneal transplant market, and strive to make "Aixin" into a national ophthalmology within two years. Brand. "

Ai Ni has successfully entered the international market

Reporter: Ai Xinyi has been on the market for more than a year. What is the clinical application?

Zhang Aibing: In China, more than 100 hospitals have introduced Ai Xinyi into clinical treatment of corneal disease. Nearly 500 patients underwent bioengineered corneal transplants to regain a better world.

After achieving certain results in the Chinese market, starting in 2016, we began to move into the global market. At present, Ai Xinyi has obtained a product registration certificate in the Philippines and entered the clinical application stage. Ai Nii signed a cooperation framework agreement with the Ethiopian and Zimbabwe Ministry of Health, and reached a three-way strategic cooperation intention with the Russian Penza state government and TITANMED Co., Ltd., and Ai Xinyi is expected to be widely used on a global scale.

Reporter: Ai Nier has been rooted in Longgang for 8 years. What changes do you think Longgang's industrial environment and entrepreneurial environment are compared with the past?

Zhang Aibing: The reason why Ai Nier chose Longgang was mainly because the industrial environment in Longgang District was good and the government supported it.

In the past 8 years, I personally feel that Longgang's entrepreneurial environment is getting better and better. The government has a strong sense of service to the company. The supporting facilities in various parks are also perfect, and there are advantages that other places do not have.

Source: Shenzhen Overseas Chinese News

RF Label

Eas anti-theft antenna is mainly suitable for large supermarkets, shopping malls, bookstores, audio stores with Security hard tags, rf soft label, AM lable,Pin and Lanyard, eas detacher, Hook Lock,EAS Self Alarm Tag, EAS Safer Box,etc.

Rf Label ,Eas Rf Label,Rf Soft Tag,Rf Security Labels

ZHEJIANG BOSHINE ELECTRONIC SECURITY CO.,LTD , https://www.boshine.com